INTRODUCTION
The phytotoxic natural product syringomycin E is a cyclic lipodepsipeptide produced by Pseudomonas syringae pv. syringae [1, 2] . The nonapeptidolactone comprising the syringomycin scaffold contains unusual amino acids at 5 of the 9 residues, including D-diaminobutyric acid, L-diaminobutyric acid, dehydro-Thr, L-threo-OH-Asp, and 4-Cl-L-Thr ( Figure 1A ). The syringomycin gene cluster in P. syringae pv. syringae B301D contains four genes relevant to syringomycin biosynthesis, namely, syrB1, syrB2, syrC, and syrE [1] . The roles of SyrB1 and SyrB2 in the generation of the 4-Cl-L-Thr residue have been well characterized. SyrB1 is an adenylation-thiolation didomain enzyme that is responsible for activating and loading L-Thr. The non-heme Fe II halogenase SyrB2 chlorinates L-Thr when it is tethered to the thiolation domain of SyrB1, thereby generating the tethered 4-Cl-L-Thr moiety that is later incorporated into the syringomycin nonapeptide [3] . SyrE is an NRPS megasynthetase composed of nine modules ( Figure 1B ), the first eight of which contain a condensation, adenylation, and thiolation domain. In contrast, the ninth module of SyrE lacks an adenylation domain, suggesting that the final amino acid, 4-Cl-Thr 9 , must be loaded onto the ninth T domain in trans.
SyrC belongs to the a/b-hydrolase superfamily and shows homology to a small group of acyltransferases that have recently been shown to be involved in other NRPS and PKS systems [4, 5] . Prior efforts to identify the role of SyrC in syringomycin biosynthesis have suggested that the enzyme may be capable of hydrolyzing the CoA moiety from long-chain fatty acids, including 3-hydroxydodecanoyl-CoA, the lipid attached to the Nterminal serine of syringomycin [6] . However, no evidence for that role has been forthcoming. Instead, we report here that SyrC is an aminoacyltransferase, shuttling the threonyl moiety in trans between the thiolation domain of SyrB1 and SyrE, setting up the final elongation to the full-length nonapeptidyl chain.
RESULTS
Cloning and Expression of SyrB1, SyrC, SyrC C224A, and SyrE 8, 9 Constructs The genes encoding the 66 kDa SyrB1 and 44 kDa SyrC were amplified from the Pseudomonas syringae pv. syringae B301D gene cluster and were cloned into N-terminally His 6 -tagged expression vectors. The SyrE-A 8 T 8 C 9 T 9 TE 160 kDa five-domain fragment (hereafter termed SyrE 8, 9 ) of the 28 kbp syrE gene was amplified and cloned in the same manner. The point mutant SyrC C224A was generated by SOE mutagenesis of the SyrC construct described above and was cloned into an N-terminally His 6 -tagged expression vector. The expression vectors for all of the constructs mentioned above were transformed into E. coli, and the proteins were expressed at 15 C after induction of the cultures with 0.1 mM IPTG. All proteins were purified by nickel-affinity chromatography (Figure 1C) . Yields of 10-15 mg protein/l culture were obtained.
Several errors were found when comparing the cloned sequences of SyrE 8, 9 and SyrC to the published sequences [1] . Multiple clones from different PCR reactions were sequenced to confirm that the errors did not result from errors incurred during PCR amplification. The correct sequences are shown in Figure S1 (see the Supplemental Data available with this article online). Similar types of errors were found in SyrB1 and SyrB2 by the original group that published the sequences, but these errors have since been corrected. The initial errors were simply due to the poor quality of the initial sequencing results, not to a difference in strains.
Demonstration of L-[
14 C]Thr Transfer from SyrB1 to SyrC; Formation of a SyrC Acyl-Enzyme Intermediate Prior work has shown that SyrB1 is the adenylation-thiolation (A-T) didomain protein that activates and then covalently tethers L-Thr in thioester linkage to the phosphopantetheinyl arm in the thiolation domain, where it then undergoes halogenation to produce 4-Cl-Thr-S-SyrB1 [3] . However, the multimodular syringomycin synthetase SyrE lacks a ninth adenylation domain to load the final 4-Cl-Thr residue onto its ninth thiolation domain (T 9 ) ( Figure 1B is readily available and can be detected by autoradiography, and since Thr 9 variants of syringomycin are known [7] .
Recombinant SyrC was incubated with phosphopantetheinylated SyrB1 (holo-SyrB1) in the presence of L-[ 14 C]Thr and ATP in HEPES buffer. Aliquots of the reaction were quenched in SDS-PAGE loading buffer at various time points, and the proteins were subjected to SDS-PAGE. The autoradiogram of the gel revealed a detectable amount of radiolabel accumulating on SyrC in a time-dependent fashion (Figure 2A ), suggesting the formation of an acyl-enzyme intermediate. This intermediate is only apparent in the absence of reducing agents, such as b-mercaptoethanol and dithiothreitol, indicating that it is quite labile to thiol nucleophiles.
Demonstration of SyrC-Mediated Transfer of L-[

C]Thr from SyrB1 to SyrE
To determine whether SyrC can mediate L- [ 14 C]Thr transfer from SyrB1 to SyrE, we used an equivalent gel-based assay as described above, but we now monitored accumulation of the radiolabeled SyrE 8,9 fragment. Both SyrB1 and SyrE 8, 9 were preincubated with the phosphopantetheinyltransferase Sfp [8, 9] to convert inactive apo forms of the thiolation domains to the HS-pantetheinylcontaining holo forms. SyrE 8, 9 has two T domains that must be posttranslationally primed. SyrC was incubated with holo-SyrB1 and holo-SyrE 8, 9 in the presence of Figures 3A and 3B ). In the absence of reducing agents, the SyrC acyl-enzyme intermediate is visible (Figure 3C ). Identification of the Catalytic Residue Necessary for Acyltransferase Activity Sequence comparison to other members of the a/b-hydrolase protein superfamily, notably CmaE [4] , CouN7, and CloN7 [5] , suggested that the thiolate side chain of Cys224 could be the catalytic nucleophile; thus, the corresponding SyrC C224A mutant was constructed, expressed, and purified ( Figure S2 ). The SyrC C224A mutant protein did not become detectably radiolabeled, suggesting that the point mutation prevents formation of the acylenzyme intermediate ( Figures 2B and 4A) . Therefore, given the first half reaction (Thr-S-SyrB1 to SyrC) and the overall reaction (Thr-S-SyrB1 to SyrE 8,9 ), we conclude that SyrC is competent to catalyze the second half reaction of the scheme depicted in Figure 4B (Thr-S-SyrC to SyrE 8, 9 ). The migrating aminoacyl moiety is shuttling between thiol nucleophiles, Cys224 in SyrC, and the HSpantetheinyl arms of the T domains in SyrB1 and SyrE.
Characterization of SyrC Amino Acid and Acceptor T Domain Specificity
Testing the selectivity of SyrC for transfer of amino acids other than L-Thr onto SyrE 8, 9 required the use of alternate aminoacyl-S-SyrB1 proteins as donor substrates. From our prior studies, SyrB1 has very high specificity for loading L-Thr and cannot load alternate amino acids to any significant extent [3] . Therefore, instead of using SyrB1 as the donor T domain, we turned to a comparable free-standing A-T didomain enzyme, CmaA from the coronamic acid biosynthetic pathway [4] . Although CmaA normally activates and tethers the allo diastereomer of L-isoleucine on its T domain, CmaA is also capable of loading L-valine, which is available in radioactive form.
When SyrC was incubated with holo-CmaA and SyrE 8, 9 in the presence of L- [ 14 C]Val and ATP in HEPES buffer and the transfer reaction was monitored by autoradiography ( Figure 5 ), the build-up of radioactive label on SyrE in Analogous logic was used to evaluate the ability of SyrC to transfer a leucyl group from an L- [ 14 C]Leu-S-T domain.
In this case, we had to turn to the barbamide cluster [10, 11] using the free-standing adenylation domain BarD and its cognate 10 kDa T domain BarA, in posttranslationally primed holo form. Purified BarD was used to adenylate and load L-[ 14 C]Leu onto holo-BarA. Next, SyrC was incubated with L- [ 14 C]Leu-S-BarA and SyrE 8, 9 , and the reaction was monitored as described above. Again, a SyrC-and time-dependent build-up of radioactive label on SyrE was observed, adding Leu and Val to Thr as shuttling aminoacyl groups for SyrC action (data not shown).
Using an autoradiographic assay, we found that SyrC is capable of transferring L- [ 14 C]-Thr from SyrB1 to the stand-alone T 9 domain. When similar experiments were done to determine whether SyrC can mediate the transfer of L- [ 14 C]Thr from SyrB1 to the alternate acceptor T domain, CmaD from the coronamic acid pathway [4] , no transfer was observed, perhaps suggesting more stringent recognition of the T domain scaffold in its acceptor mode. In future experiments, we will carry out an accurate kinetic comparison between various T 8 and T 9 constructs, embedded and excised, along with comparison of other excised domains from the nine-module SyrE protein.
Examination of SyrC Acyltransferase Specificity for the T 8 versus T 9 Domain of SyrE
Our hypothesis that SyrC acts in trans to load L-Thr onto T 9 of SyrE raises the question of whether SyrC is specific enough to distinguish T 9 from all of the other T domains in the megadalton, nine-module SyrE. Numerous attempts at site-directed mutagenesis in T 8 and T 9 of the 160 kDa SyrE 8,9 fragment were attempted, but due to the large size and high GC content of the SyrE construct, we have not been able to successfully generate the mutant constructs. Therefore, an alternate limited proteolysis approach was taken to probe SyrC specificity for T 8 versus T 9 . SyrE was loaded with L- [ 14 C]Thr via SyrB1 and SyrC as described above and then subjected to cleavage at the unique thrombin site directly preceding the T 9 domain of SyrE ( Figure 6A ). The resulting fragments were analyzed by SDS-PAGE and autoradiography. Cleavage of the SyrE 8,9 construct with thrombin results in the formation of two fragments: A 8 T 8 C 9 (118 kDa) and T 9 TE (42 kDa). If SyrC were to specifically transfer L-[ 14 C]Thr only to the T 9 domain, and not to the T 8 domain, only the 42 kDa band should be radiolabeled in the autoradiogram ( Figure 6B ). However, both the 118 kDa and 42 kDa bands are radiolabeled, suggesting that the SyrC aminoacyltransferase does not distinguish between the two domains in this transfer experiment. Future kinetic studies may reveal if there are rate differences for Thr transfer to the pantetheinyl arms of T 8 versus T 9 .
Since aminoacylation of T 8 via SyrC would jam the syringomycin assembly line, it is possible that T 8 is aminoacylated in cis via A 8 much faster than it is aminoacylated in trans via SyrC. This would prevent SyrC from misloading T 8 with threonine. To test this hypothesis, we repeated the thrombin proteolysis assay described above, but this time added nonradiolabeled L-Asp to the reaction mixture. In this case, if L-Asp were activated and loaded onto T 8 Given that SyrE 8,9 could load Asp onto T 8 and that SyrC, in the presence of SyrB1, could transfer Thr to T 9 , the question of whether the C domain in module nine could catalyze peptide bond formation arose. It did not yield detectable amounts of Asp-Thr dipeptide, so we postulate Chemistry & Biology that the amino group of Asp may need to be acylated or, perhaps, the full-length lipooctapeptidyl chain needs to be presented. To test this hypothesis, we attempted to assay for the condensation of an octapeptide substrate with L-Thr. We and then others [13] have previously reported the synthesis of peptidyl CoAs and their loading onto apo forms of T domains catalyzed by Sfp to yield peptidyl-S-T domains. In the case of SyrE 8, 9 , when b-OH-butyryl-octapeptidyl CoA was incubated with Sfp and apo SyrE 8, 9 to load either T 8 or T 9 stochastically, and then holo SyrB1, SyrC, ATP, and Thr were added, nonapeptide formation was assayed. Condensation was allowed to proceed for 1 hr, then the protein was precipitated and pelleted and the supernatant was analyzed for nonapeptide product by radio-HPLC and LC-MS. The radio-HPLC chromatogram of the supernatant shows the formation of a new peak with the same retention time as the nonapeptide standard, and there is a corresponding peak in the 220 nm UV chromatogram. This peak is not apparent in the absence of SyrE ( Figure 7A ). The LC-MS spectrum of the reaction mixture shows a mass corresponding to that of the nonapeptide, with the same retention time as the nonapeptide standard (2.4 min). Again, this mass is absent when SyrE is not present in the reaction mixture ( Figure 7B ). These preliminary data suggest that the C 9 domain catalyzes condensation of octapeptidyl substrate on T 8 with L- [ 14 C]Thr on T 9 to produce and release the linear syringomycin nonapeptide.
Subsequent efforts will determine to what extent the chain length of the b-OH-acyl substituent controls hydrolytic versus macrolactonizing release.
Formation of Syringomycin Nonapeptide Analogs Catalyzed by C 9
Since SyrC is capable of loading alternate amino acids, such as L-Val and L-Leu, onto SyrE, it is possible that the C 9 domain of SyrE could catalyze the condensation of these amino acids with the octapeptidyl substrate to generate novel syringomycin nonapeptides. Using the same methods as described above, we loaded SyrE with octapeptide and then loaded either L-Leu or L-Val onto SyrE via SyrC. Analysis by LC-MS indicates that small amounts of the alternate peptides are formed, and the low yield of the alternate peptides suggests that C 9 may not readily accept the alternate amino acids loaded onto T 9 ( Figure S4 ).
DISCUSSION
The assembly line for the nonribosomal nonapeptidolactone phytotoxin syringomycin from Pseudomonas syringae has been a mystery since the report of the syr biosynthetic gene sequence-syrB1, syrB2, syrC, syrE-and the deduced domain organization by Guenzi et al. in 1998 [1] . Notable among the mysteries was the fact that the ninemodule SyrE was missing the A domain in module nine, suggesting that the MDa protein SyrE would be incompetent to activate and load the terminal residue, Thr 9 or 4-ClThr 9 , to finish chain elongation. Further, the A domain in the free-standing A-T didomain enzyme SyrB1 was able to activate Thr. This suggested that SyrB1 was in effect the ''missing'' A 9 , and that the Thr 9 must come in trans from SyrB1 to module nine of SyrE each time a syringomycin chain is completed on the SyrE assembly line. We clarified part of the puzzle by recently demonstrating the function of SyrB2 as a novel mononuclear nonheme Fe II halogenase that acts on Thr-S-SyrB1 to produce 4-ClThr-S-SyrB1. This is the catalytic step generating the Cl-Thr 9 donor on the pantetheinyl arm of SyrB1 [3] .
In the present work, we demonstrate the function of the remaining Syr protein, the 44 kDa SyrC, and validate the in trans shuttling of Thr/Cl-Thr from SyrB1 to SyrE. When the sequence of SyrC was reported, it was clearly a member of the a/b-hydrolase superfamily. Postulated functions included thioesterase, haloperoxidase, or perhaps an acyltransferase for the N-terminal b-OH-fatty acyl moiety [1, 6] . We have previously assayed SyrC for such N-acylation activity of Ser 1 -S-SyrE without any success (R.G. Kruger, F.H.V., C.T.W., data not shown).
Two parallel efforts on other NRPS systems in which aminoacyl/acyl moieties are shuttled gave us some inkling of the function of SyrC demonstrated in this work. One was in the coronamic acid biosynthetic pathway in which the free-standing A-T didomain CmaA corresponds to SyrB1 and the nonheme iron halogenase CmaB corresponds to SyrB2 [4] . CmaE, a homolog of SyrC, shuttles an L-allo-Ile moiety between the pantetheinyl arm of the T domain of CmaA and the free-standing T domain of CmaD. Only when the aminoacyl group is presented as L-allo-Ile-S-CmaD will the CmaB halogenase recognize it [4] . CmaE is thus an aminoacyltransferase that shuttles the allo-Ile moiety between holo T domain scaffolds.
The second example is the recent demonstration that the last step in coumermycin and clorobiocin biosynthesis involves transfer of the acyl group, pyrrole-2-carbonyl, from the pantetheinyl arm of a T domain to the 3 0 -OH of the noviosyl ring of the antibiotic [5] . CmaE uses an active site Cys as a nucleophile, while CouN7 uses an active site Ser as a nucleophile, to make acyl-S-and acyl-O-enzyme intermediates, respectively, to shuttle the substrate acyl fragments between acceptors. In this context, SyrC joins this family of acyl/aminoacyl-S-pantetheinyl-T domain shuttle enzymes and solves the need for an in trans delivery of an activated Thr/Cl-Thr moiety to module nine of SyrE.
The assay of SyrC activity was not entirely straightforward. The protein scaffold for the aminoacyl donor is the 66 kDa holo form of the SyrB1 protein, which can be made in multimilligram quantities. The 4-Cl-Thr amino acyl moiety is not available in radioactive form, cannot be loaded by the A domain of SyrB1 [3] , and is not quantitatively available by action of SyrB2 on Thr-S-SyrB1. Therefore, we used L- [ 14 C]Thr as a surrogate for Cl-Thr. The acceptor substrate is even harder to come by: P. syringae SyrE has a molecular weight of 1,038,663 Da and is not readily expressable in E. coli. Of various fragments of SyrE, we chose the 160 kDa A 8 -T 8 -C 9 -T 9 -TE (deemed SyrE 8, 9 ) to express and purify in soluble form to evaluate various aspects of the last step of syringomycin assembly. In principle, SyrE 8, 9 8, 9 . Our hypothesis that SyrC, like CmaE and CouN7 [4, 5] , may engage in covalent catalysis is confirmed by autoradiography of SyrC in SDS-PAGE studies, with the thiolate side chain of Cys224 as the likely catalytic nucleophile. Thus, the shuttle enzymes CmaE and SyrC carry out energetically neutral aminoacyl transfers between thiolates of pantetheinyl prosthetic groups by way of a covalent thioester linkage in the shuttling enzyme. In contrast, CouN7, which uses a Ser-OH nucleophile, catalyzes the energetically favorable transfer of the pyrrole-2-carboxy acyl group from a pantetheinyl thioester in CouN1 to an oxoester in the pyrrolyl-coumarin antibiotic scaffold [5] .
The SyrE 8,9 fragment is not ideal for determination of the T domain selectivity of SyrC, but it appears that the itinerant L- [ 14 C]Thr can end up on the pantetheinyl forms of both T 8 and T 9 of this enzyme fragment. Whether occupancy of T 8 by the waiting octapeptidyl chain is a default director of the incoming Thr to T 9 , or there are higher-order conformer constraints in the full-length, million molecular weight SyrE is yet unknown. Presumably, transfer of the L-[ 14 C]Thr/Cl-Thr to an empty holo-T 8 would jam the assembly line and, thus, would have to be avoided or hydrolytically released. In subsequent efforts, we shall begin to address the action of C 9 and the TE domain, perhaps in a smaller C 9 -T 9 -TE construct, to begin to study the affinity of SyrC for SyrE T domains, the kinetics and specificity of transfers of the aminoacyl moiety that will become residue 9, and the permissivity of the C 9 condensation step and macrolactonization.
Given our recent detection of the three examples noted, the question of how frequently aminoacyl shuttle enzymes will turn up in NRPS assembly lines arises. They should allow in trans aminoacyl group insertions to create diversity at particular sites. If different shuttling enzymes recognize distinct sets of T domains, then it may become possible to increase positional diversity in nonribosomal peptides in their presence.
SIGNIFICANCE
The final step of the syringomycin biosynthetic assembly line, which involves the incorporation of chlorothreonine into the syringomycin scaffold, has long been a mystery due to the fact that SyrE, the megadalton syringomycin synthetase, lacks an adenylation domain in its ninth module. Prior work has shown that chlorothreonine is generated by the action of the Fe II /a-ketoglutarate-dependent halogenase SyrB2 on a threonine residue that is tethered via a phosphopantetheinyl linkage to the A-T didomain protein SyrB1. Here, we demonstrate that SyrC is an acyltransferase that is capable of shuttling threonine from SyrB1 to SyrE. Furthermore, we present preliminary data suggesting that the ninth condensation domain of SyrE is capable of catalyzing the condensation of threonyl-S-SyrE-T 9 with an octapeptidyl substrate to generate a linear nonapeptide, which is then hydrolyzed by the thioesterase domain. We also show that SyrC is capable of transferring alternate amino acids, such as leucine and valine, onto SyrE, and that these amino acids can then be incorporated into a linear nonapeptide. These results suggest that SyrC may be useful in the combinatorial enzymatic synthesis of syringomycin analogs, and they set the stage for further studies into the final steps of syringomycin biosynthesis. In addition, our identification of SyrC as an aminoacyltransferase adds another member to the small but growing family of NRPS/PKS acyltransferases that use covalent catalysis to shuttle aminoacyl groups between carrier proteins. This family of aminoacyltransferases may be useful in creating positional diversity in nonribosomal peptides.
EXPERIMENTAL PROCEDURES
Materials and General Methods
All radiolabeled chemicals were obtained from American Radiolabeled Chemicals, Inc. (ARC). L-threo-3-OH-Asp was obtained from Tocris Pharmaceuticals. All other chemicals used were from Sigma, unless otherwise specified. The TOP10-and BL21(DE3)-competent E. coli strains were purchased from Stratagene. The PfuTurbo DNA Polymerase used in PCR was purchased from Stratagene. During protein purification, cells were lysed with an Avestin Emulsiflex-C5 cell disruptor. Thrombin was obtained from Novagen. SDS polyacrylamide gels were obtained from BioRad, and autoradiography was performed on a Typhoon 9400 scanner (GE Healthcare). HPLC was carried out on a Beckman Coulter System Gold by using a Vydac C18 column. Radio-HPLC was performed on an identical system equipped with a b-Ram radioisotope detector (IN/US). LC-MS analysis was performed on an LCMS-QP8000a spectrometer (Shimadzu) with a Vydac C18 LC-MS column. Recombinant BarA and BarD were provided by Danica Galonic, and recombinant CmaA was provided by Eric Strieter.
Cloning of Syr Genes
SyrB1 was cloned as described [3] . The SyrC and SyrE 8,9 constructs were obtained by PCR amplification of genomic DNA from Pseudomonas syringae pv. syringae B301D, which was a gift from Dennis C. Gross (Texas A&M University, College Station, Texas) [14] . P. syringae pv. syringae was grown in nutrient broth-yeast extract medium at 30 C, and genomic DNA was isolated by using the Bactozol kit for bacterial DNA extraction (Molecular Research). Amplification was carried out by using PfuTurbo DNA Polymerase in accordance with the manufacturer's instructions. The following oligonucleotide primers were used in PCR amplification: SyrC: 5 0 -GGAATTCCATATGCGCGTTTG 
Site-Directed Mutagenesis of SyrC
The pET28a plasmid containing the syrC gene was used as the template for splicing by overlap extension (SOE) to generate the C224A mutant protein. The standard two-step SOE PCR method was used to create a mutation at the desired site [15] . In the first round of PCR, the 5 The two resulting fragments were purified by using the Qiagen PCR Purification kit and were then mixed and used in the second round of PCR with the forward and reverse primers from the first step. The resulting PCR product was digested with XhoI and NdeI and ligated into the pET28a plasmid. The presence of the mutation in the resulting vector was verified by sequencing. The SyrC C224A mutant protein was expressed and purified as described above.
Generation of Phosphopantetheinlyated Enzymes
Recombinant enzymes containing thiolation domains, such as SyrB1, SyrE, CmaA, and BarA, must be phosphopantetheinlyated prior to their use in assays. In a typical reaction, 1 nmol enzyme is incubated with MgCl 2 (0.5 mmol), CoA (50 nmol), Sfp (10 nmol) in 50 mM HEPES buffer (pH 7.5), in a total reaction volume of 25 ml for 30 min at room temperature to produce the holo enzyme.
Peptide synthesis was performed with a PerSeptive Biosystems 9050 synthesizer (0.3 mM scale) by using diisopropylcarbodiimide (DIPCDI)/hydroxybenzotriazole (HOBt) chemistry. The peptide was cleaved from the resin, deprotected in a single treatment with 95% trifluoroacetic acid (TFA), 2.5% water, and 2.5% triisopropylsilane (TIS) at room temperature for 3 hr. The solution was then added to cold ether dropwise, and the precipitated peptide was collected by centrifugation. The purified peptides ( Figure S3 ) were lyophilized to yield a white powder, and the identity and purity were established by analysis on LCMS.
Synthesis of Coenzyme A Derivatives of Octapeptide and Nonapeptide
The peptidyl-CoA derivatives ( Figure S3 ) were prepared based on a previously reported protocol [16] . The peptide was cleaved from the resin with 1:1:3 acetic acid:trifluoroethanol (TFE):dichloromethane (DCM) and was incubated at room temperature for 3 hr. The resin was removed by filtration, and n-hexane was added to precipitate the fully protected peptide. After rotary evaporation to remove the solvent, the peptide was redissolved in DCM and precipitated with n-hexane; this was repeated twice. The CoA coupling to the protected peptide was accomplished by the addition of 1 equivalent of CoA (Li+ salt; Sigma), 4 equivalents of potassium carbonate, and 1.5 equivalents of PyBOP in 1:1 THF:water. The reaction was mixed by tipping for 2 hr at room temperature, and then the solvent was removed by rotary evaporation followed by lyophilization. Removal of the N-terminal Boc-protecting groups was achieved by treatment with 95% TFA, 2.5% water, and 2.5% TIS at room temperature for 3 hr. The solution was then added to cold ether dropwise, and the precipitate was removed by centrifugation after overnight incubation at À20 C. The peptidyl-CoA was then dissolved in acetonitrile/water and purified by preparative HPLC on a reverse-phase C18 column with a gradient of 0%-100% acetonitrile in 0.1% TFA/water over 35 min. The pure peptidyl-CoA had a retention time of 16 min. The purified compounds were lyophilized, and the identity and purity were established by analysis in negative ion mode on LCMS and MALDI-TOF mass spectrometry: octapeptidyl-CoA 1711.5 [(M À H)
À C]Thr, SyrB1, SyrC, or SyrE were carried out as controls. The reactions were quenched in 100 ml 10% (v/v) trichloroacetic acid (TCA) to precipitate the proteins. The proteins were pelleted by centrifugation at 13,000 rpm for 20 min, and the supernatant was removed and saved (supernatant A). The pellet was washed twice with 100 ml 10% TCA and then redissolved in 100 ml 0.1M LiOH and heated to 85 C to release any peptide still bound to the SyrE 8,9 scaffold. The protein was then reprecipitated by the addition of 20 ml 50% TCA and pelleted by centrifugation, and the supernatant was removed and saved (supernatant C). The two supernatants from each reaction were analyzed by HPLC and LC-MS to determine if they contained the radiolabeled nonapeptide product. The HPLC analysis was carried out by using a Vydac C18 small-pore column with a water/acetonitrile gradient going from 0%-100% acetonitrile over 30 min. HPLC was monitored both for absorbance at 220 nm and for 14 a total volume of 500 ml with 50 mM HEPES (pH 7.5). In tandem, reactions containing no enzyme were carried out as negative controls.
Reactions were initiated by the addition of enzyme, and aliquots were quenched at 0, 1, 2, 5, 10, 20, 30, and 60 min by the addition of 750 ml of a solution containing 1.6% (w/v) activated charcoal, 200 mM sodium pyrophosphate, and 3.5% (v/v) perchloric acid. For each time point, the charcoal was pelleted by centrifugation and washed twice with 750 ml of a solution containing 200 mM sodium pyrophosphate with 3.5% perchloric acid (wash buffer). The charcoal pellet was then resuspended in 750 ml wash buffer and mixed with liquid scintillation fluid. Radioactivity bound to the charcoal was measured by liquid scintillation counting.
Assay for SyrC Specificity for SyrE 8, 9 T Domains by Thrombin Cleavage To determine whether SyrC can specifically transfer L-[ 14 C]Thr from SyrB1 to the T 9 domain of SyrE, or whether it transfers the amino acid to both T 8 and T 9 , holo-SyrE 8,9 (0.2 nmol) was loaded with L-[ 14 C]Thr via SyrC and SyrB1 as described above in a total reaction volume of 78 ml. Time points were collected at 0, 30, and 60 min, by flash freezing 20 ml aliquots of the reaction in liquid nitrogen. Then, the aliquots were thawed, and 10 ml of each aliquot was incubated with 0.1 units of thrombin in thrombin-cleavage buffer for 3 hr at 22 C. The remaining 10 ml of each aliquot was incubated under the same conditions in thrombin-cleavage buffer without the addition of thrombin as a negative control. Samples were run on a 12% SDS polyacrylamide gel, and the gel was processed as described above.
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